FAQ Directory

Here are some of the most frequently asked questions about NCQA’s various programs. If you don’t see what you are looking for in one of the entries below, you can  ask a question through My NCQA.

Filter Results
  • Save
  • Email
  • Print

5.15.2023 Social Need Screening and Intervention (SNS-E) Should the SNS-E measure include exclusion criteria for Medicare members?

No. There are no Medicare member exclusions. Remove the second bullet from Exclusion 1, which reads:

  • Medicare members 66 years of age and older by the end of the measurement period who meet either of the following:
    • Enrolled in an Institutional SNP (I-SNP) any time during the measurement period.
    • Living long-term in an institution any time during the measurement period, as identified by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file to determine if a member had an LTI flag during the measurement period.

This applies to the following Programs and Years:
Exchange MY

5.15.2023 Definition of Annual Does NCQA’s definition of “annual” allow for a 2-month grace period?

As noted in the Glossary appendix, NCQA’s long-standing definition of “annual” is 12 months plus a 2-month grace period (12–14 months). “Grace period” refers to allowing organizations to complete an activity after it is due and not before it is due.

This applies to the following Programs and Years:
CVO 2022|CM 2020|CM-LTSS 2020|HP 2023|MBHO 2023|UM-CR-PN 2023|HEA 2023

4.24.2023 Multiple Health Plan Ratings for One Product in a State How is it possible for plans to have multiple ratings for one product within a given state?

Plans can have multiple ratings for one product within the same state because they might have certain state or contractual submission requirements that fall outside of the combined submission requisite that they send to NCQA for Accreditation purposes. Therefore, this results in plans submitting one combined submission (required) for Accreditation and then they still elect to select other submissions for state or other contractual obligations, which NCQA includes as part of its Ratings program.

This applies to the following Programs and Years:

4.14.2023 Depression Screening and Follow-Up for Adolescents and Adults (DSF-E) Should the Follow-Up on Positive Screen numerator include the 12-17 years age stratification?

Yes. The 12-17 years age stratification is reported for the Follow-Up on Positive Screen numerator and should be added to the age stratification on page 240 of MY 2023 HEDIS for QRS Version.

This applies to the following Programs and Years:
Exchange MY

2.16.2023 Diabetes Measures* Should patients who have not been diagnosed with diabetes but take diabetes medications for off-label use (e.g., weight loss, heart failure) be excluded from the diabetes measures?

For measures with hybrid reporting methodology (HBD, BPD, EED), members who have not had a diagnosis of diabetes but receive diabetes medications for conditions other than diabetes (e.g., weight loss, heart failure) may be identified as valid data errors and replaced with a member from the oversample.
To meet criteria for a valid data error for these measures, the medical record must contain no evidence of diabetes and must contain evidence to substantiate the data error (how the member wound up in the measure, why it is incorrect). It is expected that the medical record will not contain evidence of diabetes, and will contain documentation that the patient is on the medication, and why. This documentation, in combination with no other documentation of diabetes in the medical record, meets criteria for a valid data error. Valid data errors are subject to review by the auditor.
Valid data errors work for the Hybrid Method only because medical record data are used to ensure that the member does not have diabetes. For the administrative method, these members remain in the measure as medical records are considered supplemental data that may not be used for identifying valid data errors, or when reporting the HBD, BPD and EED measures using the administrative method, or the KED, SMD, EDH and SPD measures, which are administrative-only measures.
We are working to refine the diabetes denominator related to off-label medication use. The next annual HEDIS public comment period is planned for February–March 2023, but organizations may submit comments on any measure, at any time, through PCS (you do not need to wait until February).

*This FAQ applies to the following measures: Hemoglobin A1c Control for Patients With Diabetes (HBD), Blood Pressure Control for Patients With Diabetes (BPD), Eye Exam for Patients With Diabetes (EED), Kidney Health Evaluation for Patients With Diabetes (KED), Statin Therapy for Patients With Diabetes (SPD), Diabetes Monitoring for People With Diabetes and Schizophrenia (SMD), and Emergency Department Visits for Hypoglycemia in Older Adults With Diabetes (EDH)

This applies to the following Programs and Years:
HEDIS MY 2023, 2022

2.15.2023 Recent updates to the MA Deeming Module NCQA updated the 2023 Medicare Advantage (MA) Deeming Module to incorporate changes mandated by the Bipartisan Budget Act of 2018 and as codified in the January 2021 Part C and D final rule. Do these changes apply to the 2022 MA Deeming Module?

Yes. The following changes apply to the 2022 MA Deeming Module:

  • MA 19, Element A:
    • Clarified that the organization’s delegation agreements for MA standards must include a statement requiring delegates to adhere to MA regulations.
  • SNP 2, Element A:
    • Revised factor 3 to reference both initial and annual health risk assessments (HRAs).
    • Clarified in the explanation that the organization must conduct an initial and annual HRA using a comprehensive HRA tool and ensure that results are addressed in the member’s individualized care plan, as required under 422.101(f)(1)(ii).
  • SNP 2, Element C:
    • Added factor 2: “The organization annually, and within the first 12 months of enrollment, conducts face-to-face encounters between the member and their care team.” The face-for-face encounter must be either in person or through visual, real-time, interactive telehealth.
    • Adjusted the scoring to reflect the new factor.
    • Revised the explanation to include “Factor 2: Face-to-face encounter” subhead and text. The encounter must be between the member and representative from any of the following:
      • The ICT.
      • The organization’s case management and coordination staff.
      • A health care provider contracted with the health plan.
  • SNP 3, Element A:
    • Revised factor 5 to read: “Including the ICT, as outlined in SNP 2, Element C, to oversee the MOC’s evaluation and monitoring process.”
    • Revised the scope of review to clarify that the organization includes the ICT in the monitoring and evaluation process.
    • Replaced the “Factor 5: Appropriate personnel” subhead with “Factor 5: The ICT” and revised the explanation to read:
      • The organizational chart documents the organization’s reporting structure and staff responsible for administering the MOC program, including the ICT, as specified in SNP 2, Element C, factor 1. According to the defined MOC, the organization must use an ICT to manage member care. The ICT includes:
        • Practitioners with demonstrated expertise and training,
        • Training in a defined role appropriate to their licensure in treating individuals similar to the targeted population of the organization, as applicable.

This applies to the following Programs and Years:
HP 2022

2.15.2023 MBHO: Use of software for evidence-based clinical guidelines for QI 8, Element F For QI 8, Element F, factor 1, is it considered delegation if an organization uses evidenced-based clinical content licensed for use in their own case management system?

No. The use of another entity’s evidence-based content within the organization’s case management system is not considered delegation if the organization maintains control over how the content is used and can customize it as needed. The evidence used to support the content must be cited.

This applies to the following Programs and Years:
MBHO 2022, 2023

2.15.2023 CM: Use of software for evidence-based clinical guidelines for CM 4, Element A For CM 4, Element A, factor 1, is it considered delegation if an organization uses evidenced-based clinical content licensed for use in their own case management system?

No. The use of another entity’s evidence-based content within the organization’s case management system is not considered delegation if the organization maintains control over how the content is used and can customize it as needed. The evidence used to support the content must be cited.

This applies to the following Programs and Years:
CM 2020

2.15.2023 Use of software for evidence-based clinical guidelines for PHM 5, Element B For PHM 5, Element B, factor 1, is it considered delegation if an organization uses evidenced-based clinical content licensed for use in their own case management system?

No. The use of another entity’s evidence-based content within the organization’s case management system is not considered delegation if the organization maintains control over how the content is used and can customize it as needed. The evidence used to support the content must be cited.

This applies to the following Programs and Years:
HP 2022, 2023

2.15.2023 Use of software to collect credentialing information Is it considered delegation if an organization uses software to only collect credentialing information?

No. The use of another entity’s software to collect credentialing information is not considered delegation unless the other entity also reviews the information on the organization's behalf. NCQA standards allow organizations to use software to collect credentialing information from approved sources, as long as organization staff document that the information was reviewed and verified.

This applies to the following Programs and Years:
HP 2022, 2023|MBHO 2022, 2023|UM-CR-PN 2022, 2023|CVO 2022|CM 2020

1.09.2023 January 2023 Summary of Updates What changes were made to the PCMH Standards and Guidelines for Version 8.1?

Topic Update Highlights
Front Matter Added definitions of “electronic health record (EHR)” and “certified electronic health record technology (CEHRT).”
TC 05 Added a note that beginning in 2024, practices will be required to have an EHR.
KM 09 Added a note that gender identify and sexual orientation requirements apply to all patients 18 years of age and older.
CM 10 Replaced “person-driven outcomes approach” with “person-centered outcomes approach.”
QI 08 & QI 09 PCMH QI 08 and QI 09: Added notes stating that if the measures reported in QI 01 or QI 02 do not leave room for improvement, practices may choose different measures within the categories to focus improvement efforts on. 

This applies to the following Programs and Years:
PCMH 2017

1.09.2023 PCSP January 2023 Summary of Updates What changes were made to the PCSP Standards and Guidelines for Version 5.1?

Topic Update Highlights
Front Matter Added definitions of “electronic health record (EHR)” and “certified electronic health record technology (CEHRT).”
TC 05 Added a note that beginning in 2024, practices will be required to have an EHR.
KM 09 Added a note that gender identify and sexual orientation requirements apply to all patients 18 years of age and older.
CM 10 Replaced “person-driven outcomes approach” with “person-centered outcomes approach.”

This applies to the following Programs and Years:
PCSP 2019